JP2003119141A5 - - Google Patents

Download PDF

Info

Publication number
JP2003119141A5
JP2003119141A5 JP2001313977A JP2001313977A JP2003119141A5 JP 2003119141 A5 JP2003119141 A5 JP 2003119141A5 JP 2001313977 A JP2001313977 A JP 2001313977A JP 2001313977 A JP2001313977 A JP 2001313977A JP 2003119141 A5 JP2003119141 A5 JP 2003119141A5
Authority
JP
Japan
Prior art keywords
hepronicart
vitamin
weight ratio
oral administration
preparation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001313977A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003119141A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001313977A priority Critical patent/JP2003119141A/ja
Priority claimed from JP2001313977A external-priority patent/JP2003119141A/ja
Priority to TW091120354A priority patent/TWI244921B/zh
Priority to CNB021439834A priority patent/CN1219514C/zh
Priority to KR1020020060903A priority patent/KR20030030882A/ko
Publication of JP2003119141A publication Critical patent/JP2003119141A/ja
Priority to HK03107057.2A priority patent/HK1054695B/xx
Publication of JP2003119141A5 publication Critical patent/JP2003119141A5/ja
Pending legal-status Critical Current

Links

JP2001313977A 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤 Pending JP2003119141A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2001313977A JP2003119141A (ja) 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤
TW091120354A TWI244921B (en) 2001-10-11 2002-09-05 Oral administration medicine with improving absorbability
CNB021439834A CN1219514C (zh) 2001-10-11 2002-09-29 具有高吸收性的口服制剂
KR1020020060903A KR20030030882A (ko) 2001-10-11 2002-10-07 흡수성을 향상시킨 경구투여 제제
HK03107057.2A HK1054695B (en) 2001-10-11 2003-09-30 Oral administration preparation improved in absorbability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001313977A JP2003119141A (ja) 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤

Publications (2)

Publication Number Publication Date
JP2003119141A JP2003119141A (ja) 2003-04-23
JP2003119141A5 true JP2003119141A5 (enExample) 2005-06-09

Family

ID=19132362

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001313977A Pending JP2003119141A (ja) 2001-10-11 2001-10-11 吸収性を向上した経口投与製剤

Country Status (4)

Country Link
JP (1) JP2003119141A (enExample)
KR (1) KR20030030882A (enExample)
CN (1) CN1219514C (enExample)
TW (1) TWI244921B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4780907B2 (ja) * 2003-09-30 2011-09-28 小林製薬株式会社 催眠剤組成物
JP4721631B2 (ja) * 2003-09-30 2011-07-13 小林製薬株式会社 催眠剤組成物
JP5094899B2 (ja) * 2010-03-23 2012-12-12 小林製薬株式会社 催眠剤組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151132A (ja) * 1984-12-24 1986-07-09 Kanebo Ltd ビタミンｋ↓２経口剤の製造法
JPS63310827A (ja) * 1987-06-15 1988-12-19 Sanwa Kagaku Kenkyusho Co Ltd ニコチン酸誘導体を主剤とする徐放性製剤
JPH10130171A (ja) * 1996-09-04 1998-05-19 Dot:Kk 経口投与用医薬組成物
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Similar Documents

Publication Publication Date Title
JP2003520232A5 (enExample)
JP2003503454A5 (enExample)
JP2004532810A5 (enExample)
JP2004523498A5 (enExample)
JP2004529078A5 (enExample)
JP2004525194A5 (enExample)
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
JP2006516528A5 (enExample)
JP2002532112A5 (enExample)
JP2003531157A5 (enExample)
JP2002506648A5 (enExample)
HUP0203556A2 (hu) Oxkarbazepint tartalmazó gyógyszerkészítmények és alkalmazásuk
JP2001522820A5 (enExample)
ZA200007548B (en) Matrix table enabling the prolonged release of trimetazidine after administration by the oral route.
JP2003526626A5 (enExample)
DE60205888D1 (de) Das citrat-salz des 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaens
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
JP2001513504A5 (enExample)
JP2006505391A5 (enExample)
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
JP2004517961A5 (enExample)
JP2002114686A5 (enExample)
JP2003119141A5 (enExample)
JP2002277470A5 (enExample)